May 18, 2020
Beijing Rongxiang Institute of Regenerative Medicine Joined Hands with Zhong Nanshan Innovation Public Welfare Fundation
—Join hands with partners to export Chinese wisdom
In May 2020, Beijing Rongxiang Institute of Regenerative Medicine became a Director Unit of Beijing Zhongnanshan Innovation Public Welfare Foundation. The purpose of Beijing Zhongnanshan Innovation Public Welfare Foundation (hereinafter referred to as "Zhongnanshan Public Welfare Foundation") is to raise public welfare funds, fund innovation achievements, and public welfare activities.
Beijing Rongxiang Institute of Regenerative Medicine has been committed to relieving human suffering and keeping human health with its regenerative medicine. It has been training doctors worldwide to export Chinese wisdom. The partnership with Zhong Nanshan Innovation Public Welfare Fundation will facilitate their social public welfare actions based on the values shared by both parties.
Kevin Xu, Chairman of the Board of Directors of MEBO Group, said that nowadays corporate social responsibility has already gone beyond the framework of business. During COVID-19, there is a necessity for company to take joint action to meet the world's biggest challenge. We have been cooperating with various parties including government, non-governmental organizations and policy makers to enhance our corporate social value. This time, we have combined international resources to fight the epidemic. We have been working hard to induce a new era of corporate social responsibility, promote the transformation of medical technology, improve human health, enhance human life value, export Chinese wisdom and make the world more inclusive.
Beijing Rongxiang Institute of Regenerative Medicine is the frontier of human regenerative life science research with “Human Body Regenerative Restoration Science” invented by Professor Rongxiang Xu as its core. It is the center of research achievements, new products and new technologies of regenerative life for MEBO Group. It trains doctors in East Asia, Southeast Asia, Africa and other regions every year and has become a carrier of CSR. Beijing Rongxiang Institute of Regenerative Medicine joined in the United Nations "Every Woman, Every Child (EWEC) Life Regenerative Action" and "The Belt and Road-Global Regenerative Medical Technology Workshop" and other international public welfare programs, and has been highly praised.
Since the emergence of COVID-19, academician Zhong Nanshan has always been on the front line of anti-epidemic battle to protect people’s lives. After the epidemic declined in China, Academician Zhong Nanshan began sharing his experience on the diagnosis and treatment of COVID-19 with foreign experts. "People's Daily" praised him for his professionalism, bravery, and sense of responsibility. The partnership between Beijing Rongxiang Institute of Regenerative Medicine and the Beijing Zhongnanshan Innovation Public Welfare Foundation will strengthen each other and further carry forward the spirit of public welfare, fulfill public welfare responsibilities and benefit the society as a whole.
Kevin Xu was invited to attend the 73rd World Health Organization WHO Conference on May 18th. Prior to this, Kevin and Clinton jointly launched COVID-19 Student Action Fund.